The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIronveld Regulatory News (IRON)

Share Price Information for Ironveld (IRON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0675
Bid: 0.067
Ask: 0.068
Change: 0.00 (0.00%)
Spread: 0.001 (1.493%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.0675
IRON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim results for the 6 months ended 31 Dec 2020

30 Mar 2021 07:00

RNS Number : 8620T
Ironveld PLC
30 March 2021
 

 

30 March 2021

 

IRONVELD PLC

("Ironveld" or the "Company")

 

Interim results for the six months ended 31 December 2020

 

Ironveld plc, the owner of a High Purity Iron ("HPI"), Vanadium and Titanium project located on the Northern Limb of the Bushveld Complex in Limpopo Province, South Africa (the "Project") is pleased to announce its interim results for the six months ended 31 December 2020 ("the period").

 

Highlights

 

Operational

 

· Overheads incurred during the period reflected continued low level of activity whilst negotiations for development funding continued; and

· Board Change - departure of Vred von Ketelhodt as full time CFO in order to reduce overhead cost base.

 

Financial

 

· Placing completed in December 2020 raised gross proceeds of £1.15 million following the agreed lapse of the IIG Option Agreement originally entered into in March 2020;

· Loans and other liabilities totalling over £1.4 million were settled in shares, thereby strengthening the Group's balance sheet position; and

· Talks at an advanced stage with a major partner seeking to take a strategic equity stake in the Company at a premium to the current share price.

 

 

Martin Eales, CEO, said:

 

"The six months to December 2020 ultimately proved frustrating and despite best efforts, we were unable to conclude the envisaged transaction with IIG. We have, however, made material progress on a possible alternative transaction in the early part of this year, which we hope to conclude in the coming weeks.

 

"We thank our shareholders for their support in the recent equity Placing and look forward to providing further updates as we make continued progress."

  

 

 

For further information, please contact:

 

Ironveld plc

Martin Eales, Chief Executive Officer

c/o Blytheweigh

020 7138 3204

 

 

 

finnCap (Nomad and Broker)

Christopher Raggett

Charlie Beeson

 

020 7220 0500

 

 

 

 

Turner Pope (Joint Broker)

Andy Thacker

Zoe Alexander

 

020 3657 0050

Blytheweigh

Megan Ray

Tim Blythe

 

020 7138 3204

 

 

Notes to Editors:

 

Ironveld (IRON.LN) is the owner of a High Purity Iron (HPI), Vanadium and Titanium project located on the Northern Limb of the Bushveld Complex in Limpopo Province South Africa. Ironveld expects to mine its own VTM ore as feedstock for a 7.5 MW DC smelter which will produce speciality iron products including high purity iron powder as well as vanadium and titanium slag products.

 

The Definitive Feasibility Study published in April 2014 confirms the project's viability to deliver an exceptionally high-grade iron product (99.5% Fe) called High Purity Iron which commands a premium in the market place. Vanadium and Titanium slag containing commercial grades of vanadium and titanium will also be produced and sold.

Ironveld is an AIM traded company. For further information on Ironveld please refer to www.ironveld.com.

 

 

Chairman's Statement:

 

During the period, despite the best efforts of all parties involved, over many months, to secure an appropriate funding solution, the IIG Option agreement (originally announced in March 2020) lapsed at the end of November 2020 and the Company then announced an equity Placing to raise gross proceeds of £1.15 million which was approved by shareholders in December. IIG provided financing of US$650,000 to Ironveld during the life of the Option Agreement and the majority of this was settled in shares at 0.42p, being a premium to the Placing Price.

 

Administrative expenses of £458,000 (2019: £278,000) were incurred in the period, with the majority of the increase represented by additional Board costs compared to the prior period following the appointment of Martin Eales as CEO in December 2019 and professional costs relating to the IIG Option agreement and the Placing.

 

Your Board remains confident that the Company's asset, containing 27 million tons of HPI, together with significant Vanadium and Titanium content, continues to demonstrate robust economics and has a potential value many times in excess of the Company's market capitalisation and balance sheet carrying value.

The fundamentals driving vanadium pricing in particular continue to be supportive as the global annual demand continues to grow, partly driven by increasing Chinese demand and the advancements in technology for vanadium redox batteries. In recent months the price of vanadium has increased strongly above 2020 levels.

The demand for HPI, as a water atomised powder, continues to increase as it is commonly used in the automotive industry, powder metallurgy and magnetic materials. Titanium slag is a key element in the development of new battery technology and is widely utilised in the steel, alloy and pigment industries.

We remain committed to operating responsibly, working closely with stakeholders and local communities at grassroots level to improve standards of living. We continue to support our 'Keep a Girl in School' initiative working alongside our local partners, The Imbumba Foundation and the Nelson Mandela Foundation, to provide hygiene support to approximately 600 female students at school in the local area. Additionally, we have commenced a new scheme in 2021 which provides facilities and support to children with maths and science homework outside of school

 

Board

In late November 2020, Vred von Ketelhodt stepped down from the Board as full time CFO, in order to reduce the Company's ongoing overhead costs and I thank him for his contributions over many years.

Financial

The Group recorded a loss before tax of £79,000 (H1 2019: £276,000) and had cash balances of £850,000 (30 June 2020: £28,000) at the end of the period. The Company does not plan to pay a dividend for the six months ended 31 December 2020.

 

In December 2020 shareholders approved an equity Placing at 0.30p per share to raise gross proceeds of £1.15 million.

 

Apart from a cash repayment of US$150,000 to IIG from the Placing proceeds, a balance of over £1.4 million, comprised of outstanding loan liabilities to IIG, other loans and accrued Directors fees, was settled in shares alongside the Placing, which has significantly improved the Group's balance sheet position. The Directors receiving shares did so at the applicable volume weighted average price over the course of their fee accruals which saw an effective issue price of 1.48p per share compared to the Placing Price of 0.30p per share.

 

Possible transaction

 

The Company is at an advanced stage in talks with an investor seeking to take a substantial strategic equity stake at the listed company level at a premium to the current share price in order to assist the Group with the next stage of its development. Whilst there are currently no guarantees that such a transaction will be completed or by when, the Directors are hopeful of being able to conclude a meaningful transaction in the coming weeks.

 

Going concern

 

Following the equity Placing in December the Group's financial resources and existing facilities are considered adequate to meet committed overhead expenditure until early 2022, by which time, the Directors anticipate completing the further funding of the Group or the Project (the High Purity Iron, Vanadium and Titanium project located on the Northern Limb of the Bushveld Complex in Limpopo Province, South Africa owned by the Group).

 

The Directors are confident that sufficient funds can be raised for this planned activity and therefore have a reasonable expectation that the Group will have adequate resources to continue in operational existence for the foreseeable future, being twelve months from the date of the approval of these interim financial statements in the absence of any further funding and therefore present these accounts on a Going Concern basis.

 

COVID-19

 

At Ironveld, the wellbeing of our people and our business is of upmost importance.

 

The Company closely follows health and travel advice as it develops in relation to COVID-19 as well as the guidance from the Governments and authorities relevant to our operations.

 

Fortunately, we are a small but dedicated team of staff at Ironveld, however, due to the importance of the situation, the Company has encouraged its staff to work from home wherever possible.

 

For Ironveld, there are currently no operations or supply chains that have been interrupted and there has been no material day to day impact other than restricted international travel which can be dealt with using electronic communications.

 

Outlook

Our current discussions regarding a strategic investment transaction give us confidence in our view that the Group's Project retains significant undeveloped value.

 

The long-term strategic focus of the Company remains to become a production led mining company as we look to monetise our vast HPI, Vanadium and Titanium resources.

 

We would like to thank all of our shareholders for their continuing support for both the Company and the Project and we look forward to providing further updates in the near future.

 

 

Giles Clarke

Chairman

30 March 2020

 

 

 

IRONVELD PLC

 

CONSOLIDATED INCOME STATEMENT

 

FOR THE PERIOD ENDED 31 DECEMBER 2020

 

6 Months

 

6 Months

 

12 Months

 

ended

 

ended

 

ended

 

31.12.20

 

31.12.19

 

30.06.20

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

Administrative expenses

(458)

 

(278)

 

(695)

Operating loss

(458)

 

(278)

 

(695)

 

 

 

 

 

 

Other gains and losses

386

 

-

 

(326)

Investment revenues

1

 

3

 

4

Finance costs

(8)

 

(1)

 

(2)

Loss before taxation

(79)

 

(276)

 

(1,019)

 

 

 

 

 

 

Taxation

-

 

-

 

-

Loss for the period

(79)

 

(276)

 

(1,019)

 

 

 

 

 

 

Attributable to owners of the company

(77)

 

(277)

 

(1,017)

Non-controlling interests

(2)

 

1

 

(2)

 

(79)

 

(276)

 

(1,019)

 

 

 

 

 

 

Profit/(loss) per share (pence)

 

 

 

 

 

 

 

 

 

 

 

Basic

(0.01p)

 

(0.04p)

 

(0.16p)

Diluted

n/a

 

n/a

 

n/a

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes form an integral part of these financial statements.

 

 

 

 

 

IRONVELD PLC

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

FOR THE PERIOD ENDED 31 DECEMBER 2020

 

 

6 Months

 

6 Months

 

12 Months

 

ended

 

ended

 

ended

 

31.12.20

 

31.12.19

 

30.06.20

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

Loss for the period

(79)

 

(276)

 

(1,019)

 

 

 

 

 

 

Exchange differences on the translation of foreign operations

1,332

 

(710)

 

(3,654)

Total comprehensive income/(loss) for the period

1,253

 

(986)

 

(4,673)

 

 

 

 

 

 

 

 

Attributable to:

 

 

 

 

 

Owners of the company

1033

 

(865)

 

(4,061)

Non-controlling interest

220

 

(121)

 

(612)

 

1,253

 

(986)

 

(4,673)

 

 

 

 

 

 

The accompanying notes for an integral part of these financial statements.

 

 

IRONVELD PLC

 

CONSOLIDATED BALANCE SHEET

 

AS AT 31 DECEMBER 2019

 

 

As at

 

 

As at

 

31.12.20

 

 

30.06.20

 

£'000

 

 

£'000

Non-current assets

 

 

 

 

Exploration and evaluation

25,586

 

 

23,574

Property, plant and equipment

2

 

 

2

Other receivables

2

 

 

2

 

25,590

 

 

23,578

Current assets

 

 

 

 

Trade and other receivables

195

 

 

76

Cash and bank balances

850

 

 

28

 

1,045

 

 

104

 

 

 

 

 

Total assets

26,635

 

 

23,682

 

 

 

 

 

Current liabilities

 

 

 

 

Trade and other payables

(258)

 

 

(805)

Borrowings

(110)

 

 

(210)

 

(368)

 

 

(1,015)

Non-current liabilities

 

 

 

 

Deferred tax liabilities

(4,698)

 

 

(4,384)

 

 

 

 

 

Total liabilities

(5,066)

 

 

(5,399)

 

 

 

 

 

Net assets

21,569

 

 

18,283

 

 

 

 

 

Equity

 

 

 

 

Share capital

10,418

 

 

9,774

Share premium

21,226

 

 

19,691

Other reserve

15

 

 

189

Retained earnings reserve

(13,419)

 

 

(14,480)

 

 

 

 

 

Equity attributable to owners of the company

18,240

 

 

15,174

Non-controlling interests

3,329

 

 

3,109

 

 

 

 

 

Total equity

21,569

 

 

18,283

 

 

 

 

 

The accompanying notes form an integral part of these financial statements.

 

IRONVELD PLC

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

FOR THE PERIOD ENDED 31 DECEMBER 2020

 

 

 

 

 

Share capital

 

Share premium

 

Retained earnings

 

 

 

Other reserve

 

Attributable to the owners of the company

 

Non-controlling interests

 

Total equity

 

£'000

 

£'000

 

£'000

 

£'000

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 1 July 2019

9,774

 

19,691

 

(10,499)

 

-

 

18,966

 

3,721

 

22,687

Loss for the year

-

 

-

 

(1,017)

 

-

 

(1,017)

 

(2)

 

(1,019)

Issue of share option

-

 

-

 

-

 

189

 

189

 

-

 

189

Exchange differences on translation of foreign operations

-

 

-

 

(3,044)

 

 

-

 

(3,044)

 

(610)

 

(3,654)

Equity settled share based payments

-

 

-

 

80

 

-

 

80

 

-

 

80

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 30 June 2020

9,774

 

19,691

 

(14,480)

 

189

 

15,174

 

3,109

 

18,283

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss for the period

-

 

-

 

(77)

 

-

 

(77)

 

(2)

 

(79)

Issue of shares and warrants

644

 

1,535

 

 

 

15

 

2,194

 

-

 

2,194

Equity settled share based payments

-

 

-

 

28

 

-

 

28

 

-

 

28

Reclassification

-

 

-

 

-

 

(189)

 

(189)

 

-

 

(189)

Exchange differences on translation of foreign operations

-

 

-

 

1,110

 

-

 

1,110

 

222

 

1,332

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 31 December 2020

10,418

 

21,226

 

(13,419)

 

15

 

18,240

 

3,329

 

21,569

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

                 

The accompanying notes for an integral part of these financial statements.

 

IRONVELD PLC

CONSOLIDATED CASH FLOW STATEMENT

FOR THE PERIOD ENDED 31 DECEMBER 2020

 

 

6 Months

 

6 Months

 

12 Months

 

Ended

 

Ended

 

Ended

 

31.12.20

 

31.12.19

 

30.06.20

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

Net cash from operating activities

(341)

 

(18)

 

(397)

 

 

 

 

 

Investing activities

 

 

 

 

 

Interest received

1

 

3

 

4

Purchase of property, plant and equipment

(1)

 

-

 

-

Purchase of exploration and evaluation assets

(264)

 

(449)

 

(555)

Net cash used in investing activities

(264)

 

(446)

 

(551)

 

 

 

 

 

 

Financing activities

 

 

 

 

 

Proceeds on issue of equity (net of costs)

1,082

 

-

 

-

Proceeds on issue of share options /warrants

-

 

-

 

189

Proceeds from new loans

354

 

-

 

210

 

 

 

 

 

 

Net cash generated in financing activities

1,436

 

-

 

399

 

 

 

 

 

 

Net increase/ (decrease) in cash and cash equivalents

831

 

(464)

 

(549)

 

 

 

 

 

 

Cash and cash equivalents at the start of the period

28

 

566

 

566

Effect of foreign exchange rates

(9)

 

5

 

11

 

 

 

 

 

 

Cash and cash equivalents at end of period

850

 

107

 

28

 

 

 

 

 

 

Note to the cash flow statement

 

 

 

 

 

Operating loss

(458)

 

(278)

 

(695)

Depreciation on property, plant and equipment

1

 

1

 

2

Share based payments

125

 

-

 

80

Operating cash flows before movements in working capital

(332)

 

(277)

 

(613)

Movement in receivables

(113)

 

79

 

61

Movement in payables

104

 

181

 

155

 

 

 

 

 

 

Cash used in operations

(341)

 

(17)

 

(397)

Interest paid

-

 

(1)

 

-

 

 

 

 

 

 

Net cash from operating activities

(341)

 

(18)

 

(397)

 

 

 

 

 

 

The accompanying notes form an integral part of these financial statements.

 

 

 

IRONVELD PLC

 

NOTES TO THE FINANCIAL STATEMENTS

 

FOR THE PERIOD ENDED 31 DECEMBER 2020

 

 

1 Basis of preparation and accounting policies

 

The results for the six months to 31 December 2020 have been prepared under International Financial Reporting Standards (IFRS) as adopted by the EU and International Accounting Standards Board.

 

The accounting policies are consistent with those of the annual financial statements for the year ended 30 June 2020, as described in those financial statements.

 

The financial information does not constitute statutory accounts as defined by section 435 of the Companies Act 2006. Full accounts of the company for the year ended 30 June 2020 on which the Auditors gave an unqualified report, have been delivered to the Registrar of Companies.

 

 

2 Loss per share

 

The calculation of basic and diluted loss per share is based upon the loss for the period and the weighted average number of ordinary shares in issue during the period.

6 Months

 

6 Months

 

12 Months

 

to 31.12.20

 

to 31.12.19

 

to 30.06.20

 

'000

 

'000

 

'000

 

 

 

 

 

 

Weighted average number of shares

714,486

 

654,991

 

654,991

Options - dilution

-

 

-

 

-

 

714,486

 

654,991

 

654,991

 

 

 

 

 

 

 

Pence

 

Pence

 

Pence

 

 

 

 

 

 

Basic loss per share - continuing

(0.01)

 

(0.04)

 

(0.16)

Diluted earnings per share

n/a

 

n/a

 

n/a

 

 

Where the Group reports a loss for any period, then in accordance with IAS 33, the share options and warrants in issue are not considered dilutive.

 

 

3 Registered office and copies of the report

 

The registered office is Ironveld plc, Unit D De Clare House Sir Alfred Owen Way, Pontygwindy Industrial Estate, Caerphilly, Wales, CF83 3HU and copies of this report are available from the registered office.

 

 

 

 

 

IRONVELD PLC

 

OFFICERS, ADVISORS AND AGENTS

 

 

Directors: Giles Clarke (Chairman) Martin Eales (Chief Executive Officer)

Nick Harrison (Non-Executive Director)

Peter Cox (Technical Director)

 

 

Secretary: Kirsti Jane Pinnell

 

Company Number: 04095614

 

Registered Office: Ironveld Plc

Unit D De Clare House Sir Alfred Owen Way

Pontygwindy Industrial Estate

Caerphilly

Wales CF83 3HU

 

Nominated Adviser finnCap

And Joint Broker: 60 New Broad Street

London

EC2M 1JJ

 

Joint Broker: Turner Pope

8 Frederick's Place

London

EC2R 8AB

Solicitors: Kuit Steinart Levy LLP

3 St Marys Parsonage

Manchester

M3 2RD

 

Auditors: UHY Hacker Young

St James Building 79 Oxford Street Manchester M1 6HT

 

Bankers: HSBC

97 Bute Street

Cardiff

CF10 5NA

 

Registrars: Link Asset Services

34 Beckenham Road

Beckenham

Kent

BR3 4TU

 

Financial PR Blytheweigh

4 - 5 Castle Court

London

EC3V 9DL

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DKCBKABKDNNB
Date   Source Headline
2nd May 20247:00 amRNSAppointment of CEO
24th Apr 20247:00 amRNSWorking Capital Facility
23rd Apr 20247:00 amRNSBlocklisting Return
2nd Apr 20245:30 pmRNSTR-1: Notification of major holdings
28th Mar 20247:00 amRNSInterim results for the 6 months ended 31 Dec 2023
29th Feb 202411:36 amRNSTR-1: Notification of major holdings
23rd Feb 20247:00 amRNSTR-1: Notification of major holdings
23rd Feb 20247:00 amRNSReceipt of Non-Binding Term Sheet and Board Change
7th Feb 20243:20 pmRNSTR-1: Notification of major holdings
2nd Feb 20241:48 pmRNSWorking Capital Facility
10th Jan 202410:45 amRNSResult of Annual General Meeting
22nd Dec 20237:00 amRNSNotice of AGM
20th Dec 20237:00 amRNSFinal Results for the year ended 30 June 2023
14th Nov 20231:40 pmRNSTR-1: Notification of major holdings
13th Nov 20232:10 pmRNSResult of General Meeting and Total Voting Rights
8th Nov 202311:50 amRNSTR-1: Notification of major holdings
7th Nov 20234:45 pmRNSTR-1: Notification of major holdings
27th Oct 20234:07 pmRNSPosting of Circular and Notice of General Meeting
26th Oct 20237:00 amRNSFundraising at a premium and Board change
23rd Oct 20237:00 amRNSBlocklisting Return
18th Sep 20237:00 amRNSOperations Update
1st Sep 20237:00 amRNSUpdate on DMS Magnetite Joint Venture
21st Jul 20232:45 pmRNSTR-1: Notification of major holdings
14th Jul 20231:06 pmRNSDirector’s Dealing
13th Jul 20232:08 pmRNSDirector’s Dealing
12th Jul 20232:50 pmRNSTR-1: Notification of major holdings
4th Jul 20238:05 amRNSTR-1: Notification of major holdings
28th Jun 20237:00 amRNSFirst Sales Achieved
27th Jun 202311:56 amRNSTR-1: Notification of major holdings
6th Jun 202310:54 amRNSIssue of Equity
5th Jun 20237:00 amRNSBoard Appointment
17th May 20232:13 pmRNSWebinar Presentation
12th May 20237:00 amRNSOperations Update
24th Apr 20237:00 amRNSBlocklisting Return
4th Apr 202312:20 pmRNSDirector Dealings
3rd Apr 20237:00 amRNSLOI signed with BurnStar Technologies
30th Mar 20237:00 amRNSInterim results for the 6 months ended 31 Dec 2022
29th Mar 202310:00 amRNSAcquisition Unconditional
15th Mar 20234:32 pmRNSTR-1: Notification of major holdings
15th Mar 202311:13 amRNSTR-1: Notification of major holdings
15th Mar 202310:58 amRNSTotal Voting Rights
13th Mar 202311:15 amRNSResult of General Meeting
2nd Mar 202311:56 amRNSTR-1: Notification of major holdings
2nd Mar 202310:15 amRNSTR-1: Notification of major holdings
1st Mar 20235:36 pmRNSDirector Dealing
1st Mar 20234:56 pmRNSTR-1: Notification of major holdings
28th Feb 20234:15 pmRNSGrant of Share Options
24th Feb 20234:00 pmRNSPosting of GM Circular
24th Feb 20231:25 pmRNSTR-1: Notification of major holdings
23rd Feb 202311:00 amRNSPlacing to raise £2.0 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.